REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 74 filers reported holding REVOLUTION MEDICINES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,481,409 | +3.5% | 1,751,496 | 0.0% | 1.07% | +6.8% |
| Q2 2023 | $46,852,518 | +160.7% | 1,751,496 | +111.1% | 1.00% | +149.4% |
| Q1 2023 | $17,972,103 | -15.4% | 829,737 | -6.9% | 0.40% | -8.9% |
| Q4 2022 | $21,237,602 | -62.8% | 891,587 | -69.2% | 0.44% | -61.2% |
| Q3 2022 | $57,022,000 | +228.1% | 2,891,587 | +224.3% | 1.14% | +217.0% |
| Q2 2022 | $17,377,000 | -23.6% | 891,587 | 0.0% | 0.36% | -29.5% |
| Q1 2022 | $22,744,000 | +1.4% | 891,587 | 0.0% | 0.51% | +7.9% |
| Q4 2021 | $22,441,000 | -47.9% | 891,587 | -43.1% | 0.47% | -44.0% |
| Q3 2021 | $43,073,000 | -13.3% | 1,565,712 | 0.0% | 0.84% | -4.8% |
| Q2 2021 | $49,696,000 | -24.6% | 1,565,712 | +9.0% | 0.88% | -36.2% |
| Q1 2021 | $65,916,000 | +19.2% | 1,436,712 | +2.9% | 1.38% | +26.7% |
| Q4 2020 | $55,283,000 | -11.6% | 1,396,383 | -22.3% | 1.09% | -28.2% |
| Q3 2020 | $62,514,000 | +10.2% | 1,796,383 | 0.0% | 1.52% | -7.9% |
| Q2 2020 | $56,712,000 | +44.1% | 1,796,383 | 0.0% | 1.65% | +32.3% |
| Q1 2020 | $39,359,000 | – | 1,796,383 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |